We are live on ! Find out more
HQL

abrdn Life Sciences Investors

82 hedge funds and large institutions have $113M invested in abrdn Life Sciences Investors in 2025 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 32 increasing their positions, 18 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

157% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 7

78% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 18

14% more funds holding

Funds holding: 7282 (+10)

2.21% less ownership

Funds ownership: 34.7%32.49% (-2.2%)

9% less capital invested

Capital invested by funds: $125M → $113M (-$11.8M)

Holders
82
Holders Change
+10
Holders Change %
+13.89%
% of All Funds
1.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
32
Reduced
18
Closed
7
Calls
Puts
Net Calls
Net Calls Change

HQL Hedge Fund Activity: Q1 2025 in Review

82 of the 7,457 institutional investors tracked by Wall St. Rank reported a position in abrdn Life Sciences Investors (HQL) for Q1 2025, worth a combined $113M — down 9.4% from $125M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new HQL positions and 7 closed out — a net gain of 11 holders — while 32 added to existing stakes and 18 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $2.07M. The largest seller was Sit Investment Associates, exiting entirely with an estimated $5.47M sold.

  • 82 institutional investors held abrdn Life Sciences Investors (HQL) as of Q1 2025, up from 72 in Q4 2024.
  • Funds reported $113M of abrdn Life Sciences Investors stock for Q1 2025, down 9.4% quarter-over-quarter.
  • 18 funds opened new abrdn Life Sciences Investors positions in Q1 2025 and 7 closed out, a net change of +11 holders.
  • The largest abrdn Life Sciences Investors buyer in Q1 2025 was Morgan Stanley, an estimated $2.07M added.
  • The largest abrdn Life Sciences Investors seller in Q1 2025 was Sit Investment Associates, an estimated $5.47M sold.

Based on aggregated 13F filings for Q1 2025.